<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:35:53Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/10527" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/10527</identifier><datestamp>2026-10-18T21:13:09Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>18β-Glycyrrhetinic acid-loaded silver nanoparticles mitigate neuroinflammation and endoplasmic reticulum stress in the brain tissue of diabetic rats</dc:title><dc:creator>Parlak, Seçil Nazife</dc:creator><dc:creator>Yakut, Seda</dc:creator><dc:creator>Kara, Adem</dc:creator><dc:creator>Demir, Özlem</dc:creator><dc:creator>Şebin, Saime Özbek</dc:creator><dc:subject>Apoptosis</dc:subject><dc:subject>Brain</dc:subject><dc:subject>Diabetes mellitus</dc:subject><dc:subject>Endoplasmic reticulum - stress</dc:subject><dc:subject>Glycyrrhetinic acid</dc:subject><dc:subject>Neuroinflammation</dc:subject><dc:subject>Oxidative stress</dc:subject><dc:subject>Silver nanoparticles</dc:subject><dc:subject>activating transcription factor 6</dc:subject><dc:subject>alloxan</dc:subject><dc:subject>caspase 3</dc:subject><dc:subject>cyclic AMP responsive element binding protein</dc:subject><dc:subject>glutathione</dc:subject><dc:subject>interleukin 1beta</dc:subject><dc:subject>ketamine</dc:subject><dc:subject>malonaldehyde</dc:subject><dc:subject>protein bcl 2</dc:subject><dc:subject>reactive oxygen metabolite</dc:subject><dc:subject>silver nanoparticle</dc:subject><dc:subject>superoxide dismutase</dc:subject><dc:subject>tumor necrosis factor</dc:subject><dc:subject>xylazine</dc:subject><dc:subject>animal experiment</dc:subject><dc:subject>animal model</dc:subject><dc:subject>animal tissue</dc:subject><dc:subject>antioxidant activity</dc:subject><dc:subject>Article</dc:subject><dc:subject>biochemical analysis</dc:subject><dc:subject>blood sampling</dc:subject><dc:subject>brain injury</dc:subject><dc:description>Objective(s): Diabetes mellitus (DM) causes oxidative stress, neuroinflammation, and endoplasmic reticulum (ER) dysfunction that contribute to neurodegeneration. This study investigated the effects of 18β-glycyrrhetinic acid-loaded silver nanoparticles (18β-GA-AgNPs) on brain injury in diabetic rats. Materials and Methods: Fifty-six male Wistar rats were divided into eight groups: Sham, 18β-GA, AgNPs, 18β-GA-AgNPs, DM, DM+18β-GA, DM+AgNPs, and DM+18β-GA-AgNPs. Diabetes was induced by alloxan (120 mg/kg, IP), and treatments were administered orally for 14 days. Biochemical markers (MDA, GSH, SOD), histopathology, and expression of ER stress and apoptotic proteins (ATF6, IRE1, Caspase-3, BCL-2, CREB, TNF-α, and IL-1β) were evaluated. Results: The DM group exhibited significant increases in MDA, TNF-α, IL-1β, ATF6, and Caspase-3 with reduced GSH, SOD, and BCL-2, indicating oxidative stress, inflammation, apoptosis, and ER stress. In contrast, IRE1 levels remained unchanged in DM rats but showed a slight elevation in the AgNPs group. Treatment with 18β-GA-AgNPs markedly reduced MDA, TNF-α, IL-1β, ATF6, and Caspase-3, while restoring GSH, SOD, BCL-2, and CREB expression. Histopathological analysis confirmed neuronal apoptosis and perivascular and extracellular space enlargement in DM rats, whereas 18β-GA-AgNPs substantially attenuated these changes. Overall, 18β-GA-AgNPs provided synergistic neuroprotection by suppressing oxidative stress, inflammation, and ER stress while enhancing antioxidant and anti-apoptotic defenses. Conclusion: These findings suggest that 18β-GA-AgNPs may represent a promising therapeutic strategy against diabetes-associated neurodegeneration, although further long-term, ultrastructural, and sex-inclusive studies are warranted. © 2026. This work is openly licensed via CC BY 4.0.</dc:description><dc:publisher>Mashhad University of Medical Sciences</dc:publisher><dc:date>2026</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/10527</dc:identifier><dc:identifier>https://doi.org/10.22038/ijbms.2025.86986.18801</dc:identifier><dc:identifier>2008-3866</dc:identifier><dc:language>en</dc:language><dc:relation>Iranian Journal of Basic Medical Sciences</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/10527</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>